Low incidence of BK virus nephropathy after simultaneous kidney pancreas transplantation

Transplantation

Volumn 82, Issue 3, 2006, Pages 382-388

  Gupta, Gaurav ^a   Shapiro, Ron ^b   Thai, Ngoc ^b   Randhawa, Parmjeet Singh ^b   Vats, Abhay ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

BK virus allograft nephropathy; Cidofovir; Graft survival; Simultaneous kidney pancreas transplantation

Indexed keywords

ALEMTUZUMAB; ANTIVIRUS AGENT; AZATHIOPRINE; CIDOFOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; BK VIRUS; BK VIRUS RENAL ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY INFECTION; KIDNEY PANCREAS TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; UNITED STATES;

ADULT; BK VIRUS; FEMALE; GRAFT SURVIVAL; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRITIS; PANCREAS TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS;

EID: 33747117318     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000228899.05501.a7     Document Type: Review

References (35)

1. Shah K. Polyomaviruses. In: Fields B, Knipe D, Howley P, eds. Fields Virology. Philadelphia: Lippincott-Raven, 1996:2027-2043.
2. Shah KV, Daniel RW, Zeigel RF, Murphy GP. Search for BK and SV40 virus reactivation in renal transplant recipients. Transplantation 1974; 17: 131.
3. Stolt A, Sasnauskas K, Koskela P, et al. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003; 84: 1499.
4. Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. A Prospective Longitudinal Study of BK Virus Infection in 104 Renal Transplant Recipients. Am J Transplant 2005; 5: 1926.
5. Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578.
6. Hogan TF, Borden EC, McBain JA, et al. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373.
7. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
8. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213.
9. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
10. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103.
11. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
12. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
13. Limaye AP, Smith KD, Cook L, et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 2005; 5: 614.
14. Schmid H, Burg M, Kretzler M, et al. BK virus associated nephropathy in native kidneys of a heart allograft recipient. Am J Transplant 2005; 5: 1562.
15. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virusassociated nephropathy in children and adults. Transplantation 2003; 75: 105.
16. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
17. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
18. Lipshutz GS, Mahanty H, Feng S, et al. Polyomavirus-associated nephropathy in simultaneous kidney-pancreas transplant recipients: a single-center experience. Transplant Proc 2004; 36: 1097.
19. Lipshutz GS, Mahanty H, Feng S, et al. BKV in simultaneous pancreaskidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant. Am J Transplant 2005; 5: 366.
20. Trofe J, Gaber LW, Stratta RJ, et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003; 5: 21.
21. Corry RJ, Chakrabarti PK, Shapiro R, et al. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg 1999; 230: 372.
22. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361.
23. Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004; 42: 1176.
24. Drachenberg CB, Papadimitriou JC, Wali R, et al. Improved outcome of polyoma virus allograft nephropathy with early biopsy. Transplant Proc 2004; 36: 758.
25. Elli A, Banfi G, Fogazzi GB, et al. BK polyomavirus interstitial nephritis in a renal transplant patient with no previous acute rejection episodes. J Nephrol 2002; 15: 313.
26. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
27. Rahamimov R, Lustig S, Tovar A, et al. BK polyoma virus nephropathy in kidney transplant recipient: the role of new immunosuppressive agents. Transplant Proc 2003; 35: 604.
28. Shapiro R, Basu A, Tan H, et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg 2005; 200: 505.
29. Li RM, Mannon RB, Kleiner D, et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002; 74: 1497.
30. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
31. Fishman JA. BK nephropathy: what is the role of antiviral therapy? Am J Transplant 2003; 3: 99.
32. Bjorang O, Tveitan H, Midtvedt K, et al. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant 2002; 17: 2023.
33. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997.
34. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3: 186.
35. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157.